SUMITOMO CHEMCL Free Cash Flow 2016-2023 | SOMMY
SUMITOMO CHEMCL free cash flow from 2016 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| SUMITOMO CHEMCL Annual Free Cash Flow |
| 2023 |
-101.60 |
| 2022 |
545.67 |
| 2021 |
2,511.27 |
| 2020 |
-114.52 |
| 2019 |
336.40 |
| 2018 |
1,451.84 |
| 2017 |
522.34 |
| 2016 |
1,531.08 |
| 2015 |
|
| SUMITOMO CHEMCL Quarterly Free Cash Flow |
| 2023-06-30 |
-1,282.44 |
| 2022-06-30 |
56.17 |
| 2022-03-31 |
545.67 |
| 2021-12-31 |
|
| 2021-09-30 |
|
| 2021-06-30 |
|
| 2021-03-31 |
2,511.27 |
| 2020-12-31 |
|
| 2020-09-30 |
|
| 2020-06-30 |
|
| 2020-03-31 |
-114.52 |
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2019-03-31 |
336.40 |
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2018-03-31 |
1,451.84 |
| 2017-12-31 |
|
| 2017-09-30 |
|
| 2017-06-30 |
|
| 2017-03-31 |
522.34 |
| 2016-12-31 |
|
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
1,531.08 |
| 2015-12-31 |
|
| 2015-09-30 |
|
| 2015-06-30 |
|
| 2015-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Diversified |
$3.349B |
$20.469B |
|
Sumitomo Chemical Co., Ltd. engages in the manufacture and sale of chemicals. Its operating segments consists of Basic Chemicals, Petrochemicals and Plastics, Information Technology related Chemicals, Health and Crop Sciences, Pharmaceuticals and Others. Basic Chemicals segment produces organic and inorganic chemicals, synthetic fiber raw materials, methyl methacrylate products, alumina products, additives and dyestuffs. Petrochemicals and Plastics segment consists of synthetic resin, rubber and other resin processed products. IT-Related Chemicals segment sells optical products, color filters, semiconductor processing materials, compound semiconductor materials and battery components. Health and Crop Sciences segment distributes fertilizers, pesticides, insecticides, tropical infectious disease control materials and feed additives. Pharmaceuticals segment develops and sells ethical pharmaceuticals, radiopharmaceutical and radiation therapy equipment. Others segment provides supply of electrical power and stea
|
